Cullinan Therapeutics, Inc. (CGEM) vs Immatics N.V. (IMTX)
A side-by-side comparison of Cullinan Therapeutics, Inc. and Immatics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGEM
Cullinan Therapeutics, Inc.
$16.45HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
IMTX
Immatics N.V.
$7.70HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — CGEM vs IMTX
growth of $100 · dividends reinvested · last 6yCGEM -46.4% (-9.9%/yr)IMTX -29.7% (-5.7%/yr)IMTX compounded faster over this window
CGEM IMTX
CGEM vs IMTX: by the numbers
- •IMTX is the larger company ($1.03B vs $1.01B market cap).
- •Both run net losses; CGEM's is the smaller (0.00% vs -493.26% net margin).
Metrics side by side
Valuation
| Metric | CGEM | IMTX |
|---|---|---|
| P/S ratio | N/A | 21.28 |
| P/B ratio | 3.14 | 2.26 |
Profitability
| Metric | CGEM | IMTX |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -377.11% |
| Net margin | 0.00% | -493.26% |
| ROE | -63.62% | -52.47% |
| ROIC | -68.64% | -53.36% |
Growth (annualized)
| Metric | CGEM | IMTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.40% |
| Total return CAGR (5Y) | -7.48% | -9.88% |
Frequently asked
- How have CGEM and IMTX total returns compared?
- Over the past 5 years, CGEM delivered -7.48% and IMTX delivered -9.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.